According to ELSO data, there were almost 5 million AF cases worldwide in 2018. Two million had the disease identified, while a further million received a false diagnosis, resulting in 3% and 6% mortality rates, respectively. Atrial fibrillation, premature ventricular contractions (PVC), atrial flutter, AV nodal re-entry tachycardia, among other arrhythmia conditions, are treated using electrophysiology mapping and ablation devices. The PVC sector dominated the market in terms of sales in 2017, with a market share of 29.0%. The high prevalence of PVCs among patients with hypertension was one of the crucial factors in its dominance over other application categories that year.
According to Data Bridge Market Research, Asia-Pacific Electrophysiology Mapping and Ablation Devices Market is USD 2180.360 million in 2022, is expected to reach USD 4917.10 million by 2030, at a CAGR of 10.7% during the forecast period 2023 to 2030.
"Increasing prevalence of cardiac arrhythmias surge market demand"
The increasing prevalence of cardiac arrhythmias, including atrial fibrillation, ventricular tachycardia, and atrial flutter, has driven the demand for electrophysiology mapping and ablation devices. These devices are essential in accurately diagnosing and effectively treating abnormal heart rhythms. With the growing number of individuals affected by these conditions, the need for advanced technologies for mapping and ablating cardiac tissue has become crucial in providing optimal care and improving patient outcomes in electrophysiology.
What restraints the growth of the Asia-Pacific electrophysiology mapping and ablation devices market?
"High cost can impede the market growth”
The high cost of electrophysiology mapping and ablation devices significantly restrain their adoption. These devices incorporate advanced technology and complex design, resulting in higher production and development costs. Limited healthcare budgets and inadequate reimbursement coverage in certain regions can further impede their adoption. The high cost poses challenges in making these devices accessible to healthcare facilities and patients, potentially limiting their widespread use and hindering optimal patient care in economically constrained regions.
Segmentation: Asia-Pacific Electrophysiology Mapping and Ablation Devices Market
The Asia-Pacific electrophysiology mapping and ablation devices market is segmented on the basis of type, indication, function, procedure, and end user.
- On the basis of type, the Asia-Pacific electrophysiology mapping and ablation devices market is segmented into ablation devices and electrophysiology mapping
- On the basis of indication, the Asia-Pacific electrophysiology mapping and ablation devices market is segmented into cardiology, cancer, cosmetic surgery, gynecology, oncology, ophthalmology, orthopedic treatment, pain management, urology, atrial flutter, atrioventricular nodal reentry tachycardia (AVNRT), atrial fibrillation, wolff-parkinson-white syndrome (WPW) and others.
- On the basis of function, the Asia-Pacific electrophysiology mapping and ablation devices market is segmented into conventional. Advanced, cryoablation, microwave and ultrasound
- On the basis of procedure, the Asia-Pacific electrophysiology mapping and ablation devices market is segmented into aesthetics-skin rejuvenation and tightening, aesthetics-body sculpting, fat reduction, and the minimization in the appearance of cellulite, benign prostatic hyperplasia, transurethral needle ablation, laser and other energy-based therapies/holmium laser ablation/enucleation of the prostate, stress urinary incontinence, menorrhagia/endometrial ablation, uterine fibroids, spinal decompression and denervation, varicose veins, atrial fibrillation, tumor ablation and others
- On the basis of end-user, the Asia-Pacific electrophysiology mapping and ablation devices market is segmented into hospitals, ambulatory surgery center, diagnostic center, cardiac catheterization laboratories, specialty clinics and others.
Regional Insights: Japan dominates the Asia-Pacific Electrophysiology Mapping and Ablation Devices Market
Japan's dominance in the Asia-Pacific electrophysiology mapping and ablation devices market is driven by several factors. The country has witnessed significant research and development activities in the field of radiofrequency ablators and electrophysiology mapping and ablation devices. This focus on innovation, advanced healthcare infrastructure, and expertise have propelled Japan's market leadership. The country's commitment to advancing technology and providing high-quality cardiac care has positioned it as a key player in the Asia-Pacific region.
To know more about the study, visit, https://www.databridgemarketresearch.com/jp/reports/asia-pacific-electrophysiology-mapping-and-ablation-devices-market
Recent Developments in Asia-Pacific Electrophysiology Mapping and Ablation Devices Market
- In 2020, The ACUSON Redwood Ultrasound System was unveiled by Siemens Healthineers AG in India. This cutting-edge tool can identify and diagnose lesions and has many applications in cardiology mapping. It increased its product lineup and stimulated the Asia-Pacific market for electrophysiology mapping and ablation devices.
- In 2019, EPIX Therapeutics, Inc. was purchased by Medtronic to diversify its product line. To treat patients with cardiac arrhythmias like atrial fibrillation, EPIX Therapeutics, Inc. is creating catheter-based, temperature-controlled cardiac ablation devices.
The Prominent Key Players Operating in the Asia-Pacific Electrophysiology Mapping and Ablation Devices Market Include:
- Abbott (U.S.)
- Arthrex, Inc. (U.S.)
- TORAY INDUSTRIES, INC. (U.S.)
- Olympus Corporation (Japan)
- Teleflex Incorporated (U.S.)
- MicroPort Scientific Corporation (China)
- BIOTRONIK SE & Co. KG. (Germany)
- Boston Scientific Corporation (U.S.)
- GE Healthcare (U.S.)
- Siemens Healthineers AG (Germany)
- Japan Lifeline Co., Ltd. (Japan)
- STARmed Co., Ltd. (South Korea)
- Koninklijke Philips N.V. (Netherlands)
- Surgnova (China)
- Medtronic (Ireland)
Above are the key players covered in the report, to know about more and exhaustive list of Asia-Pacific electrophysiology mapping and ablation devices market companies contact, https://www.databridgemarketresearch.com/jp/contact
Research Methodology: Asia-Pacific Electrophysiology Mapping and Ablation Devices Market
Data collection and base year analysis are done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. In addition, market share analysis and key trend analysis are the major success factors in the market report. The key research methodology used by dbmr research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include vendor positioning grid, market time line analysis, market overview and guide, company positioning grid, company market share analysis, standards of measurement, global vs regional and vendor share analysis. Please request analyst call in case of further inquiry.
